Learn about two of today's most effective prescription medications for chronic weight management: Semaglutide and Tirzepatide.
GLP-1 receptor agonists mimic hormones naturally produced in the body that help regulate blood sugar, slow stomach emptying, and reduce appetite. They are prescribed for Type 2 diabetes and obesity and have become an important option for long-term weight management when combined with healthy lifestyle changes.
Semaglutide is a GLP-1 receptor agonist that helps reduce appetite, improve blood sugar control, and support significant weight loss.
Tirzepatide activates both GLP-1 and GIP receptors, providing enhanced appetite control and often greater weight loss compared to GLP-1 medications alone.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Drug Class | GLP-1 Receptor Agonist | GLP-1 + GIP Receptor Agonist |
| Injection | Weekly | Weekly |
| Appetite Reduction | Excellent | Excellent+ |
| Average Weight Loss* | ≈15% Body Weight | ≈20% or More Body Weight |
| Blood Sugar Control | Excellent | Excellent |
*Results vary depending on the individual, dosage, treatment duration, and lifestyle factors.
These medications require evaluation by a qualified healthcare provider. They are not appropriate for everyone and should only be used under medical supervision. Seek immediate medical attention for severe abdominal pain, allergic reactions, or symptoms of pancreatitis.
Many people notice reduced appetite within the first few weeks. Meaningful weight loss generally develops over several months with consistent treatment.
Yes. These medications work best when combined with healthy nutrition, physical activity, adequate sleep, and long-term lifestyle changes.
Many people regain weight after stopping treatment. Discuss long-term plans with your healthcare provider before discontinuing therapy.